Cefixime Impurity G, with the CAS number 130136-31-1, is a chemical compound associated with the antibiotic cefixime, which belongs to the cephalosporin class of antibiotics. This impurity is typically a byproduct formed during the synthesis of cefixime and may arise from various degradation or reaction pathways. Its characteristics include being a solid at room temperature, with a specific molecular structure that may influence its solubility and stability. Impurities like Cefixime Impurity G are often analyzed for their potential impact on the efficacy and safety of the primary drug, as they can affect pharmacological properties and patient outcomes. The identification and quantification of such impurities are crucial in pharmaceutical quality control to ensure compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to characterize and monitor these impurities in drug formulations. Understanding the properties of Cefixime Impurity G is essential for maintaining the integrity of cefixime as a therapeutic agent.

Cefixime Impurity G

130136-31-1: Cefixime Impurity G, with the CAS number 130136-31-1, is a chemical compound associated with the antibiotic cefixime, which belongs to the cephalosporin class of antibiotics. This impurity is typically a byproduct formed during the synthesis of cefixime and may arise from various degradation or reaction pathways. Its characteristics include being a solid at room temperature, with a specific molecular structure that may influence its solubility and stability. Impurities like Cefixime Impurity G are often analyzed for their potential impact on the efficacy and safety of the primary drug, as they can affect pharmacological properties and patient outcomes. The identification and quantification of such impurities are crucial in pharmaceutical quality control to ensure compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to characterize and monitor these impurities in drug formulations. Understanding the properties of Cefixime Impurity G is essential for maintaining the integrity of cefixime as a therapeutic agent.

CAS 130136-31-1

Cefixime Impurity G

Galactose Impurity 1

Ref: 4Z-G-163016